Effect of dynamic stratified potassium supplementation in elderly patients with chronic heart failure and moderate to severe hypokalaemia—a randomised, controlled trial. Issue 10 (October 2021)

• Record Type: Journal Article
• Authors: Zheng, Tuokang; Wang, Jia; Meng, Qingbing; Zhang, Rui; Ma, Yu; Dong, Yanling; Jin, Yingli; Gao, Hengbo; Yao, Dongqi; Tian, Yingping
• Is Part Of: Journal of international medical research. Volume 49:Issue 10(2021)
• Publication Date: 2021-10
• Subjects: Potassium supplement -- chronic heart failure -- hypokalaemia -- supplementation -- elderly patient -- T wave; Medicine -- Periodicals; Pharmacology -- Periodicals; 610.5
• DOI: 10.1177/03000605211053550
• Languages: English
• ISSNs: 0300-0605

Abstract

Objective: To compare the effectiveness of dynamic stratified potassium supplementation at high concentrations with enteral potassium supplementation in older patients with chronic heart failure and moderate to severe hypokalaemia. Methods: We performed a single-centre, short-term, randomised, controlled, open-labelled, clinical trial, and patients were randomly allocated to the control or intervention group. The intervention group received intermittent infusions of 30 mmol/100 mL potassium chloride. In the control group, 10% potassium chloride was administered orally in a bolus dose. Short-term efficacy and adverse events were compared. Results: The intervention group received less potassium than that in the control group. T-wave normalisation and U-wave disappearance occurred sooner in the intervention group than in the control group after potassium supplementation. The rate of increase in potassium concentrations gradually became similar in both groups. The initial blood potassium concentration, method of potassium supplementation, potassium supplement dose, and 24-hour urinary potassium excretion significantly affected the rate of increase in blood potassium concentrations after supplementation. Conclusions: The efficacy of enteral potassium supplementation is equivalent to that of supplementation with high intravenous potassium concentrations in elderly patients with chronic heart failure and moderate to severe hypokalaemia. High intravenous potassium concentrations may lead to a superior potassium recovery rate.